Herbal therapy: a new pathway for the treatment of Alzheimer's disease

It has been a clinical challenge to treat Alzheimer's disease (AD). In the present commentary we discuss whether herbal therapy could be a novel treatment method for AD on the basis of results from clinical trials, and discuss the implications for potential therapy for AD pathophysiology. There is evidence to suggest that single herbs or herbal formulations may offer certain complementary cognitive benefits to the approved drugs. The current evidence supporting their use alone, however, is inconclusive or inadequate owing to many methodological limitations. Herbal mixtures may have advantages with multiple target regulation compared with the single-target antagonist in the view of traditional Chinese medicine. Several clinical trials using herbal mixtures are being conducted in China and will hopefully show promising results for treating AD in the near future.

[1]  H. Arai,et al.  A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. , 2005, The Journal of clinical psychiatry.

[2]  E. Ernst,et al.  Ginseng for cognitive function in Alzheimer's disease: a systematic review. , 2009, Journal of Alzheimer's disease : JAD.

[3]  P. Bria,et al.  Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study , 2006, European journal of neurology.

[4]  L. Fu,et al.  A Systematic Review of Single Chinese Herbs for Alzheimer's Disease Treatment , 2011, Evidence-based complementary and alternative medicine : eCAM.

[5]  Mohammad Reza Mohammadi,et al.  Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial , 2003, Journal of clinical pharmacy and therapeutics.

[6]  Rachelle Doody,et al.  Memantine in moderate-to-severe Alzheimer's disease. , 2003, The New England journal of medicine.

[7]  J. Olin,et al.  Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. , 2008, Current Alzheimer research.

[8]  C. Eckman,et al.  Reductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  J. Birks,et al.  Ginkgo biloba for cognitive impairment and dementia. , 2007, The Cochrane database of systematic reviews.

[10]  Zhenxin Zhang,et al.  [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]. , 2002, Zhonghua yi xue za zhi.

[11]  H. Arai,et al.  Double-Blind , Placebo-Controlled Clinical Trial of the Chinese Herbal Medicine ‘ ‘ Ba Wei Di Huang Wan ’ ’ in the Treatment of Dementia , 2004 .

[12]  J. Dungan Ginkgo biloba for Preventing Cognitive Decline in Older Adults: A Randomized Trial , 2010 .

[13]  T. Golde Alzheimer's Research & Therapy , 2009 .

[14]  Rong Wang,et al.  GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice. , 2009, Current Alzheimer research.

[15]  N. Walsh Huperzine A for Alzheimer's Disease , 2006 .

[16]  Soon-Tae Lee,et al.  Panax Ginseng Enhances Cognitive Performance in Alzheimer Disease , 2008, Alzheimer disease and associated disorders.